Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)-Reference-Cited by-同舟云学术

Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)

Published:2007-03-14 Issue:3 Volume:321 Page:1144-1153
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Suzuki Gentaroh,Kimura Toshifumi,Satow Akio,Kaneko Naoki,Fukuda Junko,Hikichi Hirohiko,Sakai Naoko,Maehara Shunsuke,Kawagoe-Takaki Hiroko,Hata Mikiko,Azuma Tomoko,Ito Satoru,Kawamoto Hiroshi,Ohta Hisashi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Behavioral and convulsant effects of the (S) enantiomer of the group I metabotropic glutamate receptor agonist 3,5-DHPG in mice

2. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests

3. Scintillation proximity assay of inositol phosphates in cell extracts: High-throughput measurement of G-protein-coupled receptor activation

4. BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.

5. Comer JEA (2003) Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability (van de Waterbeemd H, Lennernäs H, and Artursson P eds) pp 21-45, Wiley-VCH, Weinheim, Germany.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay- Dependent Pharmacology;MOL PHARMACOL;2023

2. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology;Molecular Pharmacology;2023-03-15

3. Identification of potential ferroptosis hub genes in acute-on-chronic liver failure based on bioinformatics analysis and experimental verification;BMC Medical Genomics;2023-03-11

4. International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors;Pharmacological Reviews;2020-12-23

5. Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors;PET and SPECT of Neurobiological Systems;2020-09-30